Fractyl Health, Inc. (GUTS)

Fractyl Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Revenue	0.02	0.09	0.12	-
Revenue Growth (YoY)	-85.71%	-22.50%	-	-
Cost of Revenue	-	0.05	0.08	-
Gross Profit	0.01	0.04	0.04	-
Selling, General & Admin	19.98	23.1	12.84	15.03
Research & Development	79.87	70.47	38.04	34.35
Total Operating Expenses	99.85	93.57	50.88	49.39
Operating Income	-99.84	-93.53	-50.84	-49.39
Interest Income	2.4	4.15	1.26	0.8
Other Non-Operating Income (Expense)	-2.33	20.69	-27.52	2.14
Total Non-Operating Income (Expense)	0.08	24.84	-26.26	2.93
Pretax Income	-99.77	-68.69	-77.09	-46.45
Net Income	-99.77	-70.43	-94.27	-63.63
Net Income Attributable to Preferred Dividends	-	1.74	17.18	17.18
Net Income to Common	-99.77	-70.43	-94.27	-63.63
Shares Outstanding (Basic)	49	44	2	2
Shares Outstanding (Diluted)	49	44	2	2
Shares Change (YoY)	137.62%	1992.01%	4.57%	-
EPS (Basic)	-2.15	-1.62	-45.29	-31.97
EPS (Diluted)	-2.15	-1.62	-45.29	-31.97
Free Cash Flow	-82.34	-67.29	-43.18	-46.3
Free Cash Flow Per Share	-1.69	-1.55	-20.75	-23.26
Gross Margin	58.82%	46.24%	35.83%	-
Operating Margin	-587305.88%	-100570.97%	-42363.33%	-
Profit Margin	-586864.71%	-73864.52%	-64242.50%	-
FCF Margin	-484370.59%	-72350.54%	-35985.00%	-
EBITDA	-98.85	-92.85	-50.55	-48.93
EBITDA Margin	-581470.59%	-99843.01%	-42125.00%	-
EBIT	-99.84	-93.53	-50.84	-49.39
EBIT Margin	-587305.88%	-100570.97%	-42363.33%	-

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q